| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.33B | 2.32B | 2.38B | 2.42B | 1.79B |
| Gross Profit | 1.10B | 1.10B | 1.14B | 1.18B | 804.47M |
| EBITDA | 66.72M | 35.44M | 136.66M | 190.36M | -59.66M |
| Net Income | -18.89M | -16.83M | 71.92M | 114.85M | -56.03M |
Balance Sheet | |||||
| Total Assets | 1.34B | 1.33B | 1.46B | 1.56B | 1.59B |
| Cash, Cash Equivalents and Short-Term Investments | 34.01M | 35.16M | 47.99M | 320.52M | 215.09M |
| Total Debt | 485.09M | 522.94M | 580.43M | 632.64M | 734.04M |
| Total Liabilities | 788.57M | 758.69M | 849.46M | 959.63M | 1.02B |
| Stockholders Equity | 546.97M | 571.20M | 606.97M | 602.47M | 566.76M |
Cash Flow | |||||
| Free Cash Flow | 46.75M | 34.49M | -224.82M | 185.97M | 133.61M |
| Operating Cash Flow | 87.89M | 94.80M | -164.88M | 239.87M | 157.74M |
| Investing Cash Flow | -41.13M | -60.00M | -59.93M | -33.90M | -24.02M |
| Financing Cash Flow | -47.00M | -47.58M | -45.53M | -101.17M | -3.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $523.68M | 9.10 | 8.78% | 3.12% | -6.22% | -22.81% | |
65 Neutral | $226.13M | 6.83 | 28.98% | 2.25% | -2.67% | -22.93% | |
62 Neutral | $438.66M | 49.63 | 2.79% | ― | 2.81% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $323.67M | -176.06 | -0.13% | ― | 2.76% | 96.01% | |
45 Neutral | $108.12M | -50.45 | ― | ― | -7.33% | -114.80% | |
38 Underperform | $106.85M | -1.79 | ― | ― | -10.09% | 81.44% |
On January 12, 2026, Genesco reported that for the fourth fiscal quarter-to-date period ended December 27, 2025, total comparable sales rose 9% year over year, driven by a 10% increase in same-store sales and a 9% gain in e-commerce, with Journeys Group posting a 12% comparable sales jump, Schuh up 6%, and Johnston & Murphy up 1%. Management highlighted strong holiday performance at Journeys with double-digit growth on top of last year’s double-digit gains, while noting that Schuh’s better-than-expected top line relied on heavier discounting amid a highly promotional U.K. footwear market and inventory cleanup efforts; reflecting these dynamics, the company raised its fiscal 2026 adjusted earnings outlook to at least $1.30 per share and said it would provide a fuller business and outlook update with its fourth-quarter and full-year results, as well as present its story to investors at the 2026 ICR Conference on January 12, 2026.
The most recent analyst rating on (GCO) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on Genesco stock, see the GCO Stock Forecast page.